These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32047360)

  • 1. Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018.
    Thar AMC; Wai KT; Harries AD; Show KL; Mon LL; Lin HH
    Trop Med Health; 2020; 48():4. PubMed ID: 32047360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
    Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
    Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
    Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
    Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles control in Sub-Saharan Africa: South Africa as a case study.
    Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
    Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-level determinants of failure to receive timely and complete measles vaccinations in Southwest China: a mixed methods study.
    Tang XY; Cheng M; Geater A; Deng QY; Zhong G; Lin YD; Chen N; Lan T; Jiang LY; Zhu MT; Li Q
    Infect Dis Poverty; 2021 Jul; 10(1):102. PubMed ID: 34294157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021.
    Woyessa AB; Shah MP; Azmeraye BM; Pan J; Lisanwork L; Yimer G; Wang SH; Nuorti JP; Artama M; Matanock AM; An Q; Samuel P; Tolera B; Kenate B; Bekele A; Deti T; Wako G; Shiferaw A; Tefera YL; Kokebie MA; Anbessie TB; Wubie HT; Wallace A; Sugerman CE
    Vaccines (Basel); 2024 Jul; 12(7):. PubMed ID: 39066400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles outbreak investigation at Indo-Myanmar border, Longding District, Arunachal Pradesh, India, 2017.
    Dzeyie KA; Lowang D; Dikid T; Wangsu W; Tamir T;
    Indian J Public Health; 2021 Jan; 65(Supplement):S23-S28. PubMed ID: 33753588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of measles vaccination coverage in Lincang City, Yunnan Province, China.
    Yang X; Tang T; Yang Z; Liu L; Yuan S; Zhang T
    Hum Vaccin Immunother; 2021 Sep; 17(9):3145-3152. PubMed ID: 33847247
    [No Abstract]   [Full Text] [Related]  

  • 9. Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic.
    Yang Y; Kostandova N; Mwansa FD; Nakazwe C; Namukoko H; Sakala C; Bobo P; Masumbu PK; Nachinga B; Ngula D; Carcelen AC; Prosperi C; Winter AK; Moss WJ; Mutembo S
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timeliness vaccination of measles containing vaccine and barriers to vaccination among migrant children in East China.
    Hu Y; Li Q; Luo S; Lou L; Qi X; Xie S
    PLoS One; 2013; 8(8):e73264. PubMed ID: 24013709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
    Fu H; Abbas K; Klepac P; van Zandvoort K; Tanvir H; Portnoy A; Jit M
    BMC Med; 2021 Nov; 19(1):281. PubMed ID: 34784922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress with the Second Dose Measles Vaccine Introduction and Coverage in the WHO African Region.
    Masresha BG; Shibeshi ME; Grant GB; Hatcher C; Wiysonge CS
    Vaccines (Basel); 2024 Sep; 12(9):. PubMed ID: 39340099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.
    Khanal S; Kassem AM; Bahl S; Jayantha L; Sangal L; Sharfuzzaman M; Bose AS; Antoni S; Datta D; Alexander JP
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1042-1046. PubMed ID: 35980874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of the Second Dose of Measles Containing Vaccine in the Childhood Vaccination Programs Within the WHO Africa Region - Lessons Learnt.
    Masresha BG; Luce R; Okeibunor J; Shibeshi ME; Kamadjeu R; Fall A
    J Immunol Sci; 2018 Jul; Suppl():113-121. PubMed ID: 30766972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress towards elimination of measles in Kenya, 2003-2016.
    Kisangau N; Sergon K; Ibrahim Y; Yonga F; Langat D; Nzunza R; Borus P; Galgalo T; Lowther SA
    Pan Afr Med J; 2018; 31():65. PubMed ID: 31007812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress Toward Measles Elimination - Pakistan, 2000-2018.
    Mere MO; Goodson JL; Chandio AK; Rana MS; Hasan Q; Teleb N; Alexander JP
    MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(22):505-510. PubMed ID: 31170125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.
    Ma C; Li F; Zheng X; Zhang H; Duan M; Yang Y; Hao L; Su Q; Rodewald L; Guo B; Xiao S; Wang H; Li L; Li J; Luo H; Gao L
    BMC Infect Dis; 2015 Jan; 15():23. PubMed ID: 25608672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria.
    Utazi CE; Aheto JMK; Wigley A; Tejedor-Garavito N; Bonnie A; Nnanatu CC; Wagai J; Williams C; Setayesh H; Tatem AJ; Cutts FT
    Vaccine; 2023 Jan; 41(1):170-181. PubMed ID: 36414476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles second dose vaccine utilization and associated factors among children aged 24-35 months in Sub-Saharan Africa, a multi-level analysis from recent DHS surveys.
    Chilot D; Belay DG; Shitu K; Gela YY; Getnet M; Mulat B; Muluneh AG; Merid MW; Bitew DA; Alem AZ
    BMC Public Health; 2022 Nov; 22(1):2070. PubMed ID: 36371164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.